184 related articles for article (PubMed ID: 2888463)
1. Inhibition of neutrophil degranulation and superoxide production by sulfasalazine. Comparison with 5-aminosalicylic acid, sulfapyridine and olsalazine.
Neal TM; Winterbourn CC; Vissers MC
Biochem Pharmacol; 1987 Sep; 36(17):2765-8. PubMed ID: 2888463
[TBL] [Abstract][Full Text] [Related]
2. Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.
Nielsen OH; Bouchelouche PN; Berild D; Ahnfelt-Rønne I
Scand J Gastroenterol; 1993 Jun; 28(6):527-32. PubMed ID: 8100641
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by nonsteroidal anti-inflammatory drugs of superoxide production and granule enzyme release by polymorphonuclear leukocytes stimulated with immune complexes or formyl-methionyl-leucyl-phenylalanine.
Neal TM; Vissers MC; Winterbourn CC
Biochem Pharmacol; 1987 Aug; 36(15):2511-7. PubMed ID: 3038127
[TBL] [Abstract][Full Text] [Related]
4. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
Suematsu M; Suzuki M; Miura S; Nagata H; Oshio C; Asakura H; Watanabe M; Tsuchiya M
J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of antibody secretion by 5-aminosalicylic acid.
MacDermott RP; Schloemann SR; Bertovich MJ; Nash GS; Peters M; Stenson WF
Gastroenterology; 1989 Feb; 96(2 Pt 1):442-8. PubMed ID: 2562949
[TBL] [Abstract][Full Text] [Related]
6. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
Sharon P; Drab EA; Linder JS; Weidman SW; Sabesin SM; Rubin DB
J Lab Clin Med; 1992 Jan; 119(1):99-107. PubMed ID: 1345796
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of diarrhoea producing gram negative enteric bacteria to sulfasalazine, 5-aminosalicylic acid, sulfapyridine and four quinolones. Brief report.
Andreasen JJ; Andersen LP; Hartzen SH
APMIS; 1988 Jun; 96(6):568-70. PubMed ID: 2899438
[TBL] [Abstract][Full Text] [Related]
8. Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ).
Gionchetti P; Guarnieri C; Campieri M; Belluzzi A; Brignola C; Iannone P; Miglioli M; Barbara L
Gut; 1990 Jun; 31(6):730-1. PubMed ID: 1974235
[No Abstract] [Full Text] [Related]
9. Dissociation of the 47-kilodalton protein phosphorylation from degranulation and superoxide production in neutrophils.
Sha'afi RI; Molski TF; Gomez-Cambronero J; Huang CK
J Leukoc Biol; 1988 Jan; 43(1):18-27. PubMed ID: 2826626
[TBL] [Abstract][Full Text] [Related]
10. Sulfasalazine metabolites and dapsone attenuate formyl-methionyl-leucyl-phenylalanine-induced mucosal injury in rat ileum.
von Ritter C; Grisham MB; Granger DN
Gastroenterology; 1989 Mar; 96(3):811-6. PubMed ID: 2563347
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulphasalazine and its metabolites on neutrophil chemotaxis, superoxide production, degranulation and translocation of cytochrome b-245.
Wandall JH
Aliment Pharmacol Ther; 1991 Dec; 5(6):609-19. PubMed ID: 1685923
[TBL] [Abstract][Full Text] [Related]
12. Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation.
Gionchetti P; Guarnieri C; Campieri M; Belluzzi A; Brignola C; Iannone P; Miglioli M; Barbara L
Dig Dis Sci; 1991 Feb; 36(2):174-8. PubMed ID: 1671010
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
Nielsen ST; Beninati L; Buonato CB
Scand J Gastroenterol; 1988 Apr; 23(3):272-6. PubMed ID: 2898806
[TBL] [Abstract][Full Text] [Related]
14. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
15. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
[TBL] [Abstract][Full Text] [Related]
16. The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria.
Edmond LM; Hopkins MJ; Magee EA; Cummings JH
Inflamm Bowel Dis; 2003 Jan; 9(1):10-7. PubMed ID: 12656132
[TBL] [Abstract][Full Text] [Related]
17. Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity.
Craven PA; Pfanstiel J; Saito R; DeRubertis FR
Gastroenterology; 1987 Jun; 92(6):1998-2008. PubMed ID: 2883067
[TBL] [Abstract][Full Text] [Related]
18. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
[TBL] [Abstract][Full Text] [Related]
19. The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis.
Molin L; Stendahl O
Acta Med Scand; 1979; 206(6):451-7. PubMed ID: 43662
[TBL] [Abstract][Full Text] [Related]
20. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
Miyachi Y; Yoshioka A; Imamura S; Niwa Y
Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
